Xerostomía en pacientes con fibromialgia:

Nicolas Lloves Schenone; Felix  Romanini; Marta  Mamani; Virginia  Durigan; Santiago  Scarafia; Anastasia  Secco

doi:10.47196/rar.v29i4.499

Nicolas Lloves Schenone Bernardino Rivadavia Hospital,Autonomous City of Buenos Aires, Argentina
Felix Romanini Bernardino Rivadavia Hospital,Autonomous City of Buenos Aires, Argentina
Marta Mamani Bernardino Rivadavia Hospital,Autonomous City of Buenos Aires, Argentina
Virginia Durigan Bernardino Rivadavia Hospital,Autonomous City of Buenos Aires, Argentina
Santiago Scarafia Bernardino Rivadavia Hospital,Autonomous City of Buenos Aires, Argentina
Anastasia Secco Bernardino Rivadavia Hospital,Autonomous City of Buenos Aires, Argentina

DOI: https://doi.org/10.47196/rar.v29i4.499

Keywords: fibromyalgia, xerostomia, sialometry, salivar flow, dry mouth

Abstract

Introduction: the aim of this study was to determinate the frecuency of xerostomia in patients with diagnosis of Fibromyalgia (FM) and describe their clinical characteristics.

References

I. Bellato E, Marini E, Castoldi F, et al. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat. 2012; 2012:426130.

II. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995 Jan; 38(1):19-28.

III. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990 Feb; 33(2):160-72.

IV. Wolfe F. New American College of Rheumatology criteria for fibromyalgia: a twenty-year journey. Arthritis Care and Research. 2010; 62(5):583–584.

V. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care and Research. 2010;62(5):600–610.

VI. Orellana MF, Lagravère MO, Boychuk DG, Major PW, Flores-Mir C. Prevalence of xerostomia in population-based samples: a systematic review. J Public Health Dent. 2006 Spring; 66(2):152-8.

VII. Memtsa PT, Tolia M, Tzitzikas I, Bizakis J, Pistevou-Gombaki K, Charalambidou M, Iliopoulou C, Kyrgias G. Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiation therapy. Mol Clin Oncol. 2017 May; 6(5):789-793.

VIII. Guobis Z, Baseviciene N, Paipaliene P, Sabalys G, Kubilius R. Xerostomia: Clinic, etiology, diagnosis and treatment. Medicina (Kaunas) 2006; 42:171–179.

IX. Silvestre-Donat FJ, Miralles-Jordá L, Martinez-Mihi V. Tratamiento de la boca seca: puesta al día. Med Oral 2004; 9:273-9.

X. Morais Everton Freitas de, Macedo Rômulo Augusto de Paiva, Lira Jadson Alexandre da Silva, Lima Kenio Costa de, Borges Boniek Castillo Dutra. Factors related to dry mouth and low salivary flow rates in diabetic elderly: a systematic literature review. Rev. bras. geriatr. gerontol. 2014; 17(2):417-423.

XI. Liquidato BM, Soler Rde C, Bussoloti Filho I. Evaluation of the concordance of sialometry and salivary glands scintigraphy in dry mouth patients. Braz J Otorhinolaryngol. 2006 Jan-Feb; 72(1):116-9.

XII. Agha-Hosseini F, Shirzad N, Moosavi MS. Evaluation of Xerostomia and salivary flow rate in Hashimoto’s Thyroiditis. Med Oral Patol Oral Cir Bucal. 2016 Jan 1; 21(1):e1-5.

XIII. Rad M, Kakoie S, Niliye Brojeni F, Pourdamghan N. Effect of Long-term Smoking on Whole-mouth Salivary Flow Rate and Oral Health. J Dent Res Dent Clin Dent Prospects. 2010; 4(4):110-4.

XIV. Villa A, Abati S. Risk factors and symptoms associated with xerostomia: a cross-sectional study. Aust Dent J. 2011 Sep; 56(3):290-5.

XV. Bonafede RP, Downey DC, Bennett RM. An association of fibromyalgia with primary Sjögren’s syndrome: a prospective study of 72 patients. J Rheumatol. 1995 Jan; 22(1):133-6.

XVI. Choi BY, Oh HJ, Lee YJ, Song YW. Prevalence and clinical impact of fibromyalgia in patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 2016 Mar-Apr; 34(2 Suppl 96):S9-13.

XVII. Lee YC, Lu B, Boire G, Haraoui BP, Hitchon CA, Pope JE, Thorne JC, Keystone EC, Solomon DH, Bykerk VP. Incidence and predictors of secondary fibromyalgia in an early arthritis cohort. Ann Rheum Dis. 2013 Jun; 72(6):949-54.

XVIII. Müller W, Schneider EM, Stratz T. The classification of fibromyalgia syndrome. Rheumatol Int. 2007 Sep; 27(11):1005-10.

XIX. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X; International Sjögren’s Syndrome Criteria Working Group. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 2017 Jan; 69(1):35-45.

XX. Franceschini F, Cavazzana I, Andreoli L, Tincani A. (2017). The 2016 classification criteria for primary Sjogren’s syndrome: what’s new? BMC Medicine, 15(1): 69.

Xerostomia in patients with fibromyalgia

Epidemiological study

Abstract

References

Argentine Journal of Rheumatology